2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| New Enterprise Associates 15, L.P. | 10% Owner | 4,745,262 | Dec 22, 2022 |
| George Simeon | 10% Owner | 1,658,780 | May 15, 2023 |
| Sr One Capital Management, Llc | 10% Owner | 1,658,780 | May 15, 2023 |
| Sr One Capital Partners I, Lp | 10% Owner | 1,658,780 | May 15, 2023 |
| SR One Capital Fund I Aggregator LP | 10% Owner | 1,658,780 | May 15, 2023 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 4, 2026 | Elghandour Rami | Officer | Neutral | 27.5 | -101,164 | -12.75% | ✗ | - |
| Jan 2, 2026 | Feb 27, 2026 | Elghandour Rami | Officer | Sell | 35.0 | -89,916 | -11.49% | ✗ | $10.2M |
| Jan 6, 2026 | Feb 25, 2026 | Gilson Michelle | CFO | Sell | 37.5 | -11,219 | -24.84% | ✗ | $1.3M |
| Jan 3, 2026 | Feb 19, 2026 | Gilson Michelle | CFO | Sell | 40.0 | -8,384 | -15.66% | ✗ | $572.6K |
| Jan 2, 2026 | Feb 18, 2026 | Gilson Michelle | CFO | Sell | 40.0 | -11,291 | -17.42% | ✗ | $784.8K |
| Feb 11, 2026 | Feb 13, 2026 | Elghandour Rami | Officer | Neutral | 27.5 | -198,000 | -25.99% | ✗ | - |
| Feb 11, 2026 | Feb 13, 2026 | Elghandour Rami | Officer | Neutral | 27.5 | -218,500 | -21.83% | ✗ | - |
| Jan 20, 2026 | Jan 20, 2026 | Lubner David Charles | Director | Sell | 15.0 | -6,000 | -21.69% | ✓ | $450K |
| Jan 6, 2026 | Jan 14, 2026 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 40.0 | -5,882 | -19.85% | ✗ | $403K |
| Jan 3, 2026 | Jan 13, 2026 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 40.0 | -7,437 | -20.06% | ✗ | $487.2K |
| Jan 2, 2026 | Jan 12, 2026 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 40.0 | -6,131 | -14.19% | ✗ | $393.3K |
| Jan 2, 2026 | Jan 6, 2026 | Heery Christopher | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2026 | Jan 6, 2026 | Elghandour Rami | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2026 | Jan 6, 2026 | Gilson Michelle | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 17, 2025 | Nov 17, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 13.8 | -340 | -54.49% | ✓ | $30.6K |
| Oct 15, 2025 | Oct 15, 2025 | Gilson Michelle | CFO | Sell | 7.5 | -5,364 | -38.79% | ✓ | $488.3K |
| Oct 3, 2025 | Oct 6, 2025 | Gilson Michelle | CFO | Sell | 7.5 | -5,946 | -30.07% | ✓ | $511.6K |
| Sep 30, 2025 | Sep 30, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 5.0 | -21,034 | -97.12% | ✓ | $1.7M |
| Sep 29, 2025 | Sep 29, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 53.8 | -73 | -0.34% | ✓ | $5.9K |
| Sep 26, 2025 | Sep 26, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 7.5 | -12,396 | -36.32% | ✓ | $993.2K |
| Sep 18, 2025 | Sep 19, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 26.3 | -3,643 | -9.65% | ✓ | $291.5K |
| Aug 28, 2025 | Aug 29, 2025 | Elghandour Rami | Officer | Sell | 35.0 | -546,938 | -46.95% | ✗ | $38.4M |
| Aug 12, 2025 | Aug 14, 2025 | Behbahani Ali | Director | Neutral | 90.0 | +4,207 | 992.22% | ✗ | - |
| Jun 10, 2025 | Jun 11, 2025 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $101K |
| May 29, 2025 | May 30, 2025 | Behbahani Ali | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2025 | May 30, 2025 | Galligan Andrew H | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2025 | May 30, 2025 | Patel Kavita | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2025 | May 30, 2025 | Myers Kristin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2025 | May 30, 2025 | Ware Olivia C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2025 | May 30, 2025 | Carroll Jill | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2025 | May 30, 2025 | Lubner David Charles | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 23, 2025 | May 28, 2025 | Gilson Michelle | CFO | Sell | 40.0 | -12,235 | -38.22% | ✗ | $784.8K |
| May 20, 2025 | May 20, 2025 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $87.6K |
| Apr 29, 2025 | Apr 29, 2025 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $96.3K |
| Apr 8, 2025 | Apr 8, 2025 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $86.3K |
| Mar 18, 2025 | Mar 20, 2025 | Myers Kristin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 18, 2025 | Mar 20, 2025 | Galligan Andrew H | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 20, 2025 | Myers Kristin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 20, 2025 | Galligan Andrew H | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 18, 2025 | Mar 18, 2025 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $107.5K |
| Feb 27, 2025 | Feb 27, 2025 | Elghandour Rami | Officer | Neutral | 90.0 | +1,015,671 | 680.81% | ✗ | - |
| Feb 7, 2025 | Feb 26, 2025 | Elghandour Rami | Officer | Sell | 37.5 | -38,300 | -20.43% | ✗ | $2.4M |
| Feb 25, 2025 | Feb 25, 2025 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $94.7K |
| Feb 7, 2025 | Feb 24, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 40.0 | -10,155 | -21.32% | ✗ | $647.8K |
| Feb 7, 2025 | Feb 11, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 7, 2025 | Feb 11, 2025 | Elghandour Rami | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 4, 2025 | Feb 4, 2025 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $96.9K |
| Jan 14, 2025 | Jan 14, 2025 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $98.8K |
| Jan 3, 2025 | Jan 10, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 40.0 | -7,783 | -23.68% | ✗ | $581.3K |
| Jan 3, 2025 | Jan 10, 2025 | Gilson Michelle | CFO | Sell | 5.0 | -18,009 | -65.27% | ✓ | $1.4M |
| Jan 3, 2025 | Jan 10, 2025 | Elghandour Rami | Officer | Sell | 37.5 | -30,311 | -20.54% | ✗ | $2.3M |
| Jan 2, 2025 | Jan 10, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 40.0 | -5,950 | -15.33% | ✗ | $466.2K |
| Jan 2, 2025 | Jan 10, 2025 | Gilson Michelle | CFO | Sell | 40.0 | -11,243 | -28.95% | ✗ | $881K |
| Jan 2, 2025 | Jan 10, 2025 | Elghandour Rami | Officer | Sell | 37.5 | -30,223 | -17.00% | ✗ | $2.4M |
| Jan 2, 2025 | Jan 6, 2025 | Gilson Michelle | CFO | Sell | 40.0 | -10,604 | -27.31% | ✗ | $831.4K |
| Jan 2, 2025 | Jan 6, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 40.0 | -6,362 | -16.39% | ✗ | $498.8K |
| Jan 2, 2025 | Jan 6, 2025 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 40.0 | -6,362 | -16.39% | ✗ | $498.8K |
| Jan 2, 2025 | Jan 6, 2025 | Elghandour Rami | Officer | Sell | 37.5 | -28,633 | -16.10% | ✗ | $2.2M |
| Dec 24, 2024 | Dec 26, 2024 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $115.5K |
| Dec 3, 2024 | Dec 5, 2024 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $137.8K |
| Nov 15, 2024 | Nov 19, 2024 | Gilson Michelle | CFO | Sell | 10.0 | -1,761 | -100.00% | ✓ | $156.5K |
| Nov 12, 2024 | Nov 14, 2024 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $159.5K |
| Nov 8, 2024 | Nov 12, 2024 | Gilson Michelle | CFO | Sell | 5.0 | -12,354 | -87.52% | ✓ | $1.2M |
| Nov 7, 2024 | Nov 12, 2024 | Patel Kavita | Director | Sell | 3.8 | -57,479 | -50.36% | ✓ | $6M |
| Oct 22, 2024 | Oct 22, 2024 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $134.5K |
| Oct 1, 2024 | Oct 3, 2024 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $123.4K |
| Sep 17, 2024 | Sep 17, 2024 | Gilson Michelle | CFO | Sell | 5.0 | -15,000 | -68.45% | ✓ | $1.2M |
| Sep 10, 2024 | Sep 12, 2024 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $111.6K |
| Sep 5, 2024 | Sep 6, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 10.0 | -3,421 | -26.94% | ✓ | $239.5K |
| Sep 3, 2024 | Sep 3, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 5.0 | -27,451 | -74.74% | ✓ | $1.8M |
| Aug 26, 2024 | Aug 28, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 5.0 | -21,684 | -70.03% | ✓ | $1.5M |
| Aug 20, 2024 | Aug 22, 2024 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $98.8K |
| Aug 16, 2024 | Aug 19, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 7.5 | -5,450 | -37.00% | ✓ | $354.5K |
| Aug 1, 2024 | Aug 2, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 5.0 | -20,000 | -68.31% | ✓ | $1.2M |
| Jul 30, 2024 | Aug 1, 2024 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $92.9K |
| Jul 16, 2024 | Jul 18, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 7.5 | -10,901 | -54.02% | ✓ | $711.9K |
| Jul 11, 2024 | Jul 12, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 12.5 | -5,451 | -22.71% | ✓ | $327.5K |
| Jul 9, 2024 | Jul 11, 2024 | Patel Kavita | Director | Sell | 10.0 | -1,500 | -100.00% | ✓ | $84.9K |
| Jul 1, 2024 | Jul 3, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 5.0 | -20,000 | -68.31% | ✓ | $1.1M |
| Jun 27, 2024 | Jun 28, 2024 | Patel Kavita | Director | Sell | 7.5 | -10,000 | -100.00% | ✓ | $542.7K |
| Jun 26, 2024 | Jun 28, 2024 | Gilson Michelle | CFO | Sell | 7.5 | -12,877 | -65.06% | ✓ | $691.5K |
| Jun 12, 2024 | Jun 14, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 5.0 | -20,000 | -68.31% | ✓ | $1.1M |
| May 28, 2024 | Jun 6, 2024 | Behbahani Ali | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2024 | Jun 6, 2024 | Carroll Jill | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2024 | Jun 6, 2024 | Yoon Derek | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2024 | Jun 6, 2024 | Ware Olivia C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2024 | Jun 6, 2024 | Patel Kavita | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2024 | Jun 6, 2024 | Lubner David Charles | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 23, 2024 | May 24, 2024 | Gilson Michelle | CFO | Sell | 40.0 | -12,121 | -37.98% | ✗ | $614.7K |
| May 1, 2024 | May 3, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 7.5 | -18,168 | -67.03% | ✓ | $932.6K |
| Apr 16, 2024 | Apr 18, 2024 | Ware Olivia C | Director | Sell | 7.5 | -9,402 | -100.00% | ✓ | $522.3K |
| Apr 1, 2024 | Apr 3, 2024 | Elghandour Rami | Officer | Sell | 5.0 | -23,086 | -25.00% | ✓ | $1.5M |
| Mar 22, 2024 | Mar 26, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 5.0 | -46,815 | -31.05% | ✓ | $3.3M |
| Mar 21, 2024 | Mar 25, 2024 | Carroll Jill | Director | Sell | 15.0 | -504,263 | -25.42% | ✗ | $35.6M |
| Mar 18, 2024 | Mar 18, 2024 | Gilson Michelle | CFO | Sell | 7.5 | -6,825 | -41.85% | ✓ | $473.3K |
| Mar 15, 2024 | Mar 18, 2024 | Ware Olivia C | Director | Sell | 7.5 | -9,000 | -100.00% | ✓ | $633.6K |
| Feb 8, 2024 | Feb 12, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Sell | 40.0 | -10,111 | -25.02% | ✗ | $640.4K |
| Feb 8, 2024 | Feb 12, 2024 | Elghandour Rami | Officer | Sell | 37.5 | -38,065 | -29.19% | ✗ | $2.4M |
| Feb 7, 2024 | Feb 9, 2024 | Heery Christopher | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 7, 2024 | Feb 9, 2024 | Elghandour Rami | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |